Muhamad Alhaj Moustafa

机构：WinnMed, Mayo Clinic in Florida · ORCID：0000-0001-8582-1219

发表论文 197 篇 · 总被引 789 次 · h-index 15

代表论文

• Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma (2025 · Blood Advances · 被引 7)
• Multi‐Institutional Study of ALK ‐Positive Large B‐Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies (2025 · American Journal of Hematology · 被引 3)
• Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma (2025 · Clinical Cancer Research · 被引 2)
• The Role of Radiation Therapy in the Management of Gray Zone Lymphoma (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 2)
• Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study (2025 · Blood · 被引 1)
• Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma (2025 · Blood · 被引 1)